American College of Radiology Imaging Network
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, American College of Radiology Imaging Network sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
American College of Radiology Imaging Network: 14 sponsored US clinical trials, none currently recruiting.
American College of Radiology Imaging Network sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Contralateral Breast Cancer, with 1 trials.
Top-decile sponsor footprint
American College of Radiology Imaging Network ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
14 total, page 1 of 1
DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
NCT01564368
Monitoring and Predicting Chemotherapy Response Using DOSI
NCT01217385
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
NCT00424138
Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
NCT00132041
The National CT Colonography Trial
NCT00084929
Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer
NCT00072501
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer
NCT00032058
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
NCT00058058
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
NCT00043017
Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)
NCT00023868
Radiofrequency Ablation in Treating Patients With Bone Metastases
NCT00026247
Digital Mammography Screening Trial (ACRIN6652)
NCT00008346
Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia
NCT00005809
MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients
NCT00004936
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Therapeutic Areas
How the American College of Radiology Imaging Network archive is shaped
14 indexed studies, none listed as recruiting (0% open); 12 completed (86%).
Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).
Top condition: Contralateral Breast Cancer (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
American College of Radiology Imaging Network: archived-pipeline peers nationwide
Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
American College of Radiology Imaging Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 archived trials
- 3-C Institute for Social Development · 14 trials · 0% recruiting
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this American College of Radiology Imaging Network page
14 registered trials is a research-attention snapshot, not an endorsement of American College of Radiology Imaging Network or any single study.
- None of American College of Radiology Imaging Network's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Contralateral Breast Cancer is the condition American College of Radiology Imaging Network studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Contralateral Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
American College of Radiology Imaging Network pipeline card: 14 registered trials from official public datasets.Report a data error.